Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of “Buy” by Brokerages
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have been assigned an average rating of “Buy” from the eleven analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to […]
